ImageneBio, Inc. Insider Trading

IMA

⊜ Compare

Last 12 months

Insiders bought 96K and sold 17K on the open market.

None of the selling was scheduled in advance under a 10b5-1 plan.

Net open-market

+79K

1 buy · 1 sale

Under a 10b5-1 plan

of the value sold

Insiders who bought / sold

1 / 1

executives and directors

Last open-market buy

Dec 2025

Dec 24, 2025

Get an email when IMA's executives or directors buy, or make a large sale outside a plan.

Trades · last 2 years

Date	Insider	Trade	Shares	Price	Value	Of their stake	Filing
Jul 16 – 17	Robert B Lally Principal Accounting Officer	SoldNo plan 2 parts	3,196	$5.42 average	17K	5.4%	Form 4
Dec 24, 2025	Joseph P Slattery Director	Bought	16,000	$5.99	96K	New	Form 4
Jul 25, 2025	David P Bonita Director	Bought	83,611	$29.90	$2.5M	38%	Form 4
Jul 25, 2025	Otello Stampacchia Director	Bought	267,556	$29.90	$8M	142%	Form 4

Jul 16 – 17No plan
Robert B Lally
Principal Accounting Officer · sold 3,196 at avg $5.42
17K
5.4% of stake
Dec 24, 2025
Joseph P Slattery
Director · bought 16,000 at $5.99
96K
New position
Jul 25, 2025
David P Bonita
Director · bought 83,611 at $29.90
$2.5M
38% of stake
Jul 25, 2025
Otello Stampacchia
Director · bought 267,556 at $29.90
$8M
142% of stake

How to read this. Insiders sell for many reasons: taxes, diversifying, a house. Open-market buys are rarer and say more. A 10b5-1 plan is a trading schedule set up months in advance, so those sales were not timed on news. Large holders (funds and 10% owners) are listed under Everything but not counted as insiders. If you own or watch IMA, we send a push when an executive buys or makes a large sale outside a plan.

Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.

Peers

Biological Products, (No Diagnostic Substances) · Pick stocks to compare with IMA

CompareIntrinsic value

PROKProKidney Corp

$1.12+4.67%10

CRDFCardiff Oncology Inc.

$0.87+1.03%36

PLURPluri Inc.

$1.23-3.15%30

INBXInhibrx Biosciences, Inc.

$86.76+7.01%15

SCNIScinai Immunotherapeutics Ltd.

$0.45-4.92%30

ZIVOZivo Bioscience Inc.

$8.00+10.34%0

ATYRAtyr Pharma Inc.

$6.18-6.79%10

OTLKOutlook Therapeutics Inc.

$0.46+0.46%10

Spot a number that looks wrong? Check it in IMA's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

2 of 2 free stocks used today

Keep analysing IMA

Create a free account and get 14 days of Premium: every stock and every tool.

Unlimited stocksQuality, fair value and dividends for 10,000+ stocks
Stock screenerFilter on quality, valuation and dividend safety
Portfolio trackerReal return, dividend calendar and portfolio quality
Editable DCFChange the assumptions and watch fair value move
Compare side by sideUp to 10 stocks in one table
Unlimited alertsPrice, P/E, Quality Score and yield

No card. Moves to Free after, unless you upgrade.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.